Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04760899 · ClinicalTrials.gov registry record · NA

Cerebellar TDCS for SRPCS Treatment

A NA study of Post-Concussion Syndrome, sponsored by University of Iowa.

Active
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT04760899 is a NA study of Post-Concussion Syndrome that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 31 participants, below the 58-participant average among 14 other Post-Concussion Syndrome trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04760899, a NA study of Post-Concussion Syndrome, is active but no longer recruiting, sponsored by University of Iowa.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

This study is investigating the immediate and long-term effects of bilateral cerebellar transcranial direct current stimulation on cognition, balance, and symptom severity in people with sports-related post-concussion syndrome. The central hypothesis is that tDCS will provide improvements in cognitive deficits, balance, and overall symptom attenuation in people with SRPCS both acutely and at 2 and 4 week follow ups. The researchers further hypothesize that cerebellar tDCS will ameliorate the symptoms of people with SRPCS.

Conditions Studied

Interventions

  • DEVICE Transcranial Direct Current Stimulation

Study Locations (1)

Iowa

  • Thorsten of Rudroff - Iowa City

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2021-03-01
Est. Completion 2027-07
Phase NA

Sponsor

University of Iowa

228 total trials

What the Registry Record Tells You About NCT04760899

The ClinicalTrials.gov registry entry for NCT04760899 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 14 other Post-Concussion Syndrome trials with a reported enrollment target (47% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Concussion Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Direct Current Stimulation is the first listed.

NCT04760899 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT04760899 about?

NCT04760899 is a clinical study titled "Cerebellar TDCS for SRPCS Treatment". This study is investigating the immediate and long-term effects of bilateral cerebellar transcranial direct current stimulation on cognition, balance, and symptom severity in people with sports-related post-concussion syndrome. The central hypothesis is that tDCS will provide improvements in cogniti...

What is the current status of trial NCT04760899?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2021-03-01. Estimated completion is 2027-07.

What conditions does trial NCT04760899 study?

This clinical trial studies the following conditions: Post-Concussion Syndrome.

What interventions are being tested in trial NCT04760899?

The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04760899?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04760899 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Concussion Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.